Differential gene expression in a rat model of depression based on persistent differences in exploratory activity

European Neuropsychopharmacology

Volumn 20, Issue 5, 2010, Pages 288-300

  Alttoa, Aet ^a   Kõiv, Kadri ^a   Hinsley, Timothy A ^b   Brass, Andrew ^b   Harro, Jaanus ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Anxiety; Depression; Exploratory behaviour; Gene expression; Microarrays; Novelty

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA1; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; 5 HYDROXYTRYPTAMINE RECEPTOR 1A; 5 HYDROXYTRYPTAMINE RECEPTOR 2C; AQUAPORIN 4; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II BETA SUBUNIT; CANNABINOID 1 RECEPTOR; GLIA MATURATION FACTOR; GLIA MATURATION FACTOR BETA; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR IONOTROPIC AMPA3; GLUTAMATE RECEPTOR IONOTROPIC N METHYL ASPARATE 2A; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA Q POLYPEPTIDE; KALIRIN RHOGEF KINASE; LIMBIC SYSTEM ASSOCIATED MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 5; MYELIN BASIC PROTEIN; NEUROLIGIN; NEUROLIGIN 2; PROTEIN KINASE; SEROTONIN; TRYPTOPHAN HYDROXYLASE 2; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN REGION; CELL STRUCTURE; DEPRESSION; DOWN REGULATION; FRONTAL CORTEX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HIPPOCAMPUS; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; REGULATORY MECHANISM; UPREGULATION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; GENE EXPRESSION; GENE EXPRESSION PROFILING; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR;

EID: 77950300004     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2009.09.005     Document Type: Article

References (104)

1. Ackermann T.F., Hortnagl H., Wolfer D.P., Colacicco G., Sohr R., Lang F., Hellweg R., Lang U.E. Phosphatidylinositide dependent kinase deficiency increases anxiety and decreases GABA and serotonin abundance in the amygdala. Cell. Physiol. Biochem. 2008, 22:735-744.
2. Alfonso J., Aguero F., Sanchez D.O., Flugge G., Fuchs E., Frasch A.C., Pollevick G.D. Gene expression analysis in the hippocampal formation of tree shrews chronically treated with cortisol. J. Neurosci. Res. 2004, 78:702-710.
3. 2 receptor function in rats with high or low exploratory activity. Neuroscience 2005, 132:979-990.
4. 2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus. Brain Res. 2007, 1131:138-148.
5. Alttoa A., Seeman P., Kõiv K., Eller M., Harro J. Rats with persistently high exploratory activity have both higher extracellular dopamine levels and higher proportion of D(2) (High) receptors in the striatum. Synapse 2009, 63:443-446.
6. Beaulieu J.M. Not only lithium: regulation of glycogen synthase kinase-3 by antipsychotics and serotonergic drugs. Int. J. Neuropsychopharmacol. 2007, 10:3-6.
7. Beaulieu J.M., Zhang X., Rodriguiz R.M., Sotnikova T.D., Cools M.J., Wetsel W.C., Gainetdinov R.R., Caron M.G. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1333-1338.
8. Beechey C.V., Cattanach B.M., Blake A., Peters J. MRC Harwell, Oxfordshire World Wide Web Site-Mouse Imprinting Data and References http://www.har.mrc.ac.uk/research/genomic_imprinting/.
9. Bhansali P., Dunning J., Singer S.E., David L., Schmauss C. Early life stress alters adult serotonin 2C receptor pre-mRNA editing and expression of the alpha subunit of the heterotrimeric G-protein G q. J. Neurosci. 2007, 27:1467-1473.
10. Blundell J., Tabuchi K., Bolliger M.F., Blaiss C.A., Brose N., Liu X., Südhof T.C., Powell C.M. Increased anxiety-like behavior in mice lacking the inhibitory synapse cell adhesion molecule neuroligin 2. Genes Brain Behav. 2009, 8:114-126.
11. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on bias and variance. Bioinformatics 2003, 19:185-193.
12. Boothman L., Raley J., Denk F., Hirani E., Sharp T. In vivo evidence that 5-HT2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br. J. Pharmacol. 2006, 149:861-869.
13. Bouras C., Kovari E., Hof P.R., Riederer B.M., Giannakopoulos P. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol. 2001, 102:373-379.
14. Boyce-Rustay J.M., Holmes A. Genetic inactivation of the NMDA receptor NR2A subunit has anxiolytic- and antidepressant-like effects in mice. Neuropsychopharmacology 2006, 31:2405-2414.
15. Catania E.H., Pimenta A., Levitt P. Genetic deletion of Lsamp causes exaggerated behavioral activation in novel environments. Behav. Brain Res. 2008, 188:380-390.
16. Chen J.-T., Lu D.-H., Chia C.-P., Ruan D.-Y., Sabapathy K., Xiao Z.-C. Impaired long-term potentiation in c-Jun N-terminal kinase 2-deficient mice. J. Neurochem. 2005, 93:463-473.
17. Ciani L., Salinas P.C. WNTS in the vertebrate nervous system: from patterning to neuronal connectivity. Nat. Rev. Neurosci. 2005, 6:351-362.
18. B receptor interactions in rat hippocampal membranes. Neurochem. Int. 2008, 52:1402-1409.
19. Clemett D.A., Punhani T.S., Duxon M., Blackburn T.P., Fone K.C.F. Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 2000, 39:123-132.
20. Coppe A., Danieli G.A., Bortoluzzi S. REEF: searching regionally enriched features in genomes. BMC Bioinformatics 2006, 7:453.
21. Deakin J.F.W. 5-HT, antidepressant drugs and the psychosocial origins of depression. J. Psychopharmacol. 1996, 10:31-38.
22. Diehl L.A., Silveira P.P., Leite M.C., Crema L.M., Portella A.K., Billodre M.N., Nunes E., Henriques T.P., Fidelix-da-Silva L.B., Heis M.D., Goncalves C.A., Quillfeldt J.A., Dalmaz C. Long lasting sex-specific effects upon behavior and S100b levels after maternal separation and exposure to a model of post-traumatic stress disorder in rats. Brain Res. 2007, 1144:107-116.
23. Dierssen M., Gratacos M., Sahun I., Martin M., Gallego X., Amador-Arjona A., Martinez de Lagran M., Murtra P., Marti E., Pujana M.A., Ferrer I., Dalfo E., Martinez-Cue C., Florez J., Torres-Peraza J.F., Alberch J., Maldonado R., Fillat C., Estivill X. Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction. Neurobiol. Dis. 2006, 24:403-418.
24. Dunning M.J., Smith M.L., Ritchie M.E., Tavare S. beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 2007, 23:2184-2185.
25. Fan Y., Zhang J., Sun X.L., Gao L., Zeng X.N., Ding J.H., Cao C., Niu L., Hu G. Sex- and region-specific alterations of basal amino acid and monoamine metabolism in the brain of aquaporin-4 knockout mice. J. Neurosci. Res. 2005, 82:458-464.
26. Feng Y., Vetro A., Kiss E., Kapornai K., Daroczi G., Mayer L., Tamas Z., Baji I., Gadoros J., King N., Kennedy J.L., Wigg K., Kovacs M., Barr C.L. Association of the neurotrophic tyrosine kinase receptor 3 (NTRK3) gene and childhood-onset mood disorders. Am. J. Psychiatry 2008, 165:610-616.
27. Frame S., Cohen P. GSK3 takes centre stage more than 20years after its discovery. Biochem. J. 2001, 359:1-16.
28. Garcia-Garcia A.L., Elizalde N., Matrov D., Harro J., Wojcik S.M., Venzala E., Ramirez M.J., Rio J.D., Tordera R.M. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol. Psychiatry 2009, 2009(66):275-282.
29. Gottschalk W.A., Jiang H., Tartaglia N., Feng L., Figurov A., Lu B. Signaling mechanisms mediating BDNF modulation of synaptic plasticity in the hippocampus. Learn. Mem. 1999, 6:243-256.
30. Gould T.D., Chen G., Manji H.K. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology 2003, 29:32-38.
31. Gould T.D., Dow E.R., O'Donnell K.C., Chen G., Manji H.K. Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway. CNS Neurol. Disord. Drug Targets 2007, 6:193-204.
32. Gould T.D., Einat H., O'Donnell K.C., Picchini A.M., Schloesser R.J., Manji H.K. [beta]-Catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 2007, 32:2173-2183.
33. Gould T.D., O'Donnell K.C., Picchini A.M., Dow E.R., Chen G., Manji H.K. Generation and behavioral characterization of [beta]-catenin forebrain-specific conditional knock-out mice. Behav. Brain Res. 2008, 189:117-125.
34. Griebel G. 5-hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30years of research. Pharmacol. Ther. 1995, 65:319-395.
35. Haller J., Varga B., Ledent C., Barna I., Freund T.F., Matyas F., Soproni K., Barsy B., Nemeth B., Mikics E., Hajos N. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur. J. Neurosci. 2004, 19:1906-1912.
36. Haller J.A., Varga B.A., Ledent C.B., Freund T.F.A. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav. Pharmacol. 2004, 15:299-304.
37. Haller J., Matyas F., Soproni K., Varga B., Barsy B., Nemeth B., Mikics E., Freund T.F., Hajos N. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur. J. Neurosci. 2007, 25:2445-2456.
38. Harro J. Measurement of exploratory behaviour in rodents. Methods in Neurosciences 1993, vol. 14:359-377. Academic Press, San Diego.
39. Harro J., Oreland L., Vasar E., Bradwejn J. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur. Neuropsychopharmacol. 1995, 5:447-455.
40. Heasley L.E., Storey B., Fanger G.R., Butterfield L., Zamarripa J., Blumberg D., Maue R.A. GTPase-deficient G alpha 16 and G alpha q induce PC12 cell differentiation and persistent activation of cJun NH2-terminal kinases. Mol. Cell. Biol. 1996, 16:648-656.
41. Heisler L.K., Zhou L., Bajwa P., Hsu J., Tecott L.H. Serotonin 5-HT2C receptors regulate anxiety-like behavior. Genes Brain Behav. 2007, 6:491-496.
42. Herdegen T., Mielke K., Kallunki T. Review: c-Jun and the c-Jun amino-terminal kinases: bipotential components of the neuronal stress response. Neuroscientist 1999, 5:147-154.
43. Hino S.-I., Kishida S., Michiue T., Fukui A., Sakamoto I., Takada S., Asashima M., Kikuchi A. Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein. Mol. Cell. Biol. 2001, 21:330-342.
44. Hooks M.S., Colvin A.C., Juncos J.L., Justice J.B. Individual differences in basal and cocaine-stimulated extracellular dopamine in the nucleus accumbens using quantitative microdialysis. Brain Res. 1992, 587:306-312.
45. Huang da W., Sherman B.T., Tan Q., Kir J., Liu D., Bryant D., Guo Y., Stephens R., Baseler M.W., Lane H.C., Lempicki R.A. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acid Res. 2007, 35:W169-175.
46. Hurst L.D., Pál C., Lercher M.J. The evolutionary dynamics of eukaryotic gene order. Nat. Rev., Genet. 2004, 299-310.
47. Kabbaj M. Individual differences in vulnerability to drug abuse: the high responders/low responders model. CNS Neurol. Disord. Drug Targets 2006, 5:513-520.
48. Kalueff A.V., Nutt D.J. Role of GABA in anxiety and depression. Depress. Anxiety 2007, 24:495-517.
49. Kantor S., Anheuer Z.E., Bagdy G. High social anxiety and low aggression in Fawn-Hooded rats. Physiol. Behav. 2000, 71:551-557.
50. 1A receptors in Fawn-Hooded rats after chronic fluoxetine. Eur. Neuropsychopharmacol. 2001, 11:15-24.
51. Khawaja X., Xu J., Liang J.J., Barrett J.E. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies. J. Neurosci. Res. 2004, 75:451-460.
52. Kleppisch T., Voigt V., Allmann R., Offermanns S. G(alpha)q-deficient mice lack metabotropic glutamate receptor-dependent long-term depression but show normal long-term potentiation in the hippocampal CA1 region. J. Neurosci. 2001, 21:4943-4948.
53. Kong H., Sha L.L., Fan Y., Xiao M., Ding J.H., Wu J., Hu G. Requirement of AQP4 for antidepressive efficiency of fluoxetine: implication in adult hippocampal neurogenesis. Neuropsychopharmacology 2009, 34:1263-1276.
54. Landgraf R., Wigger A. High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav. Genetics 2002, 32:301-314.
55. Lesch K.P., Gutknecht L. Focus on the 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics. Int. J. Neuropsychopharmacol. 2004, 7:381-385.
56. Lesch K.P., Hough C.J., Aulakh C.S., Wolozin B.L., Tolliver T.J., Hill J.L., Akiyoshi J., Chuang D.M., Murphy D.L. Fluoxetine modulates G protein alpha s, alpha q, and alpha 12 subunit mRNA expression in rat brain. Eur. J. Pharmacol. 1992, 227:233-237.
57. Leussis M.P., Andersen S.L. a sIs adolescenceensitive period for depression? Behavioral and neuroanatomical findings from a social stress model. Synapse 2008, 62:22-30.
58. Li Q., Wichems C.H., Ma L., Van de Kar L.D., Garcia F., Murphy D.L. Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J. Neurochem. 2003, 84:1256-1265.
59. Li X., Zhu W., Roh M.S., Friedman A.B., Rosborough K., Jope R.S. In vivo regulation of glycogen synthase kinase-3beta (GSK-3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology 2004, 29:1426-1431.
60. Li F., Chong Z.Z., Maiese K. Vital elements of the Wnt-Frizzled signaling pathway in the nervous system. Curr. Neurovasc. Res. 2005, 2:331-340.
61. Li Z., Gao L., Liu Q., Cao C., Sun X.L., Ding J.H., Hu G. Aquaporin-4 knockout regulated cocaine-induced behavior and neurochemical changes in mice. Neurosci. Lett. 2006, 403:294-298.
62. Li X., Rosborough K.M., Friedman A.B., Zhu W., Roth K.A. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int. J. Neuropsychopharmacol. 2007, 10:7-19.
63. Liu R., Jolas T., Aghajanian G. Serotonin 5-HT2 receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. Brain Res. 2000, 873:34-45.
64. Logan C.Y.., Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 2004, 20:781-810.
65. Ma X.M., Kiraly D.D., Gaier E.D., Wang Y., Kim E.J., Levine E.S., Eipper B.A., Mains R.E. Kalirin-7 is required for synaptic structure and function. J. Neurosci. 2008, 28:12368-12382.
66. Ma X.M., Wang Y., Ferraro F., Mains R.E., Eipper B.A. Kalirin-7 is an essential component of both shaft and spine excitatory synapses in hippocampal interneurons. J Neurosci. 2008, 28:711-724.
67. Mällo T., Alttoa A., Kõiv K., Tõnissaar M., Eller M., Harro J. Rats with persistently low or high exploratory activity: behaviour in tests of anxiety and depression, and extracellular levels of dopamine. Behav. Brain Res. 2007, 177:269-281.
68. Mällo T., Kõiv K., Koppel I., Raudkivi K., Uustare A., Rinken A., Timmusk T., Harro J. Regulation of extracellular serotonin levels and brain-derived neurotrophic factor in rats with high and low exploratory activity. Brain Res. 2008, 1194:110-117.
69. Margis R., Zanatto V.C., Tramontina F., Vinade E., Lhullier F., Portela L.V., Souza D.O., Dalmaz C., Kapczinski F., Goncalves C.A. Changes in S100B cerebrospinal fluid levels of rats subjected to predator stress. Brain Res. 2004, 1028:213-218.
70. Matrov D., Kolts I., Harro J. Cerebral oxidative metabolism in rats with high and low exploratory activity. Neurosci. Lett. 2007, 413:154-158.
71. Menard J., Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev. 1999, 23:591-613.
72. Nelovkov A., Philips M.A., Koks S., Vasar E. Rats with low exploratory activity in the elevated plus-maze have the increased expression of limbic system-associated membrane protein gene in the periaqueductal grey. Neurosci. Lett. 2003, 352:179-182.
73. Novak G., Seeman P., Tallerico T. Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression. Synapse 2006, 59:61-68.
74. Ogata H., Goto S., Sato K., Fujibuchi W., Bono H., Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999, 27:29-34.
75. Otter M.H., Matto V., Sõukand R., Skrebuhhova T., Allikmets L., Harro J. Characterization of rat exploratory behavior using the exploration box test. Methods Find. Exp. Clin. Pharmacol. 1997, 19:683-691.
76. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. 1998, 95:10734-10739.
77. Pawlak C.R., Ho Y.-J., Schwarting R.K.W. Animal models of humans psychopathology based on individual differences in novelty-seeking and anxiety. Neurosci. Biobehav. Rev. 2008, 32:1544-1568.
78. Peineau S., Bradley C., Taghibiglou C., Doherty A., Bortolotto Z.A., Wang Y.T., Collingridge G.L. The role of GSK-3 in synaptic plasticity. Br. J. Pharmacol. 2008, 153:S428-S437.
79. Peters J., Beechey C. Identification and characterisation of imprinted genes in the mouse. Brief Funct. Genomic Proteomic 2004, 2:320-333.
80. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
81. Qi H., Ma J., Liu Y.M., Yang L., Peng L., Wang H., Chen H.Z. Allostatic tumor-burden induces depression-associated changes in hepatoma-bearing mice. J. Neuro-oncol. 2009, 94:367-372.
82. Raman M., Chen W., Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 2007, 26:3100-3112.
83. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc. Natl. Acad. Sci. 1998, 95:14476-14481.
84. Rattray M., Liu X., Sanguinetti G., Milo M., Lawrence N.D. Propagating uncertainty in microarray data analysis. Brief. Bioinfomatics 2006, 7:37-47.
85. Rothermundt M., Peters M., Prehn J.H., Arolt V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 2003, 60:614-632.
86. Rouge-Pont F., Deroche V., Le Moal M., Piazza P.V. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur. J. Neurosci. 1998, 10:3903-3907.
87. Sahún I., Gallego X., Gratacos M., Murtra P., Trullas R., Maldonado R., Estivill X., Dierssen M. Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry. Amino Acids 2007, 33:677-688.
88. Sanacora G., Zarate C.A., Krystal J.H., Manji H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev., Drug Discov. 2008, 7:426-437.
89. Scaccianoce S., Del Bianco P., Pannitteri G., Passarelli F. Relationship between stress and circulating levels of S100B protein. Brain Res. 2004, 1004:208-211.
90. Serrats J., Mengod G., Cortés R. Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei. J. Chem. Neuroanat. 2005, 29:83-91.
91. Shiah I.S., Yatham L.N. GABA function in mood disorders: an update and critical review. Life Sci. 1998, 63:1289-1303.
92. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22:3251-3261.
93. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 2001, 76:1-10.
94. Takamori S. VGLUTs: 'exciting' times for glutamatergic research?. Neurosci. Res. 2006, 55:343-351.
95. Tordera R.M., Totterdell S., Wojcik S.M., Brose N., Elizalde N., Lasheras B., Del Rio J. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur. J. Neurosci. 2007, 25:281-290.
96. Toth M. 5-HT1A receptor knockout mouse as a genetic model of anxiety. Eur. J. Pharmacol. 2003, 463:177-184.
97. Urigüen L., Arteta D., Diez-alarcia R., Ferrer-Alcon M., Diaz A., Pazos A., Meana J.J. Gene expression patterns in brain cortex of three different animal models of depression. Genes Brain Behav. 2008, 7:649-658.
98. Varoqueaux F., Jamain S., Brose N. Neuroligin 2 is exclusively localized to inhibitory synapses. Eur. J. Cell. Biol. 2004, 83:449-456.
99. Wang H., Zhu Y.Z., Wong P.T., Farook J.M., Teo A.L., Lee L.K., Moochhala S. cDNA microarray analysis of gene expression in anxious PVG and SD rats after cat-freezing test. Exp. Brain Res. 2003, 149:413-421.
100. White D.A., Kalinichev M., Holtzman S.G. Locomotor response to novelty as a predictor of reactivity to aversive stimuli in the rat. Brain Res. 2007, 1149:141-148.
101. 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 1995, 351:357-373.
102. Zaheer A., Weiss J.L., Goyal P., Lim R. Enhanced expression of neurotrophic factors by C6 rat glioma cells after transfection with glia maturation factor. Neurosci. Lett. 1999, 265:203-206.
103. Zhang X., Beaulieu J.-M., Sotnikova T.D., Gainetdinov R.R., Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004, 305:217.
104. Zhang X., Gainetdinov R.R., Beaulieu J.-M., Sotnikova T.D., Burch L.H., Williams R.B., Schwartz D.A., Krishnan K.R.R., Caron M.G. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 2005, 45:11-16.